Effects of miR-145-5p through NRAS on the cell proliferation, apoptosis, migration, and invasion in melanoma by inhibiting MAPK and PI3K/AKT pathways
出版年份 2017 全文链接
标题
Effects of miR-145-5p through NRAS on the cell proliferation, apoptosis, migration, and invasion in melanoma by inhibiting MAPK and PI3K/AKT pathways
作者
关键词
-
出版物
Cancer Medicine
Volume 6, Issue 4, Pages 819-833
出版商
Wiley
发表日期
2017-03-24
DOI
10.1002/cam4.1030
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase, PIM1, in melanoma
- (2016) Zhen Rang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Roads to melanoma: Key pathways and emerging players in melanoma progression and oncogenic signaling
- (2016) Jasmina Paluncic et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma
- (2016) Hamed Mirzaei et al. EUROPEAN JOURNAL OF CANCER
- Computational Modeling of PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer
- (2016) Francesco Pappalardo et al. PLoS One
- Inhibition of SW620 human colon cancer cells by upregulating miRNA-145
- (2016) Chen Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1α
- (2015) Jianda Zhou et al. CANCER BIOLOGY & THERAPY
- Targeting drivers of melanoma with synthetic small molecules and phytochemicals
- (2015) Leah Ray Strickland et al. CANCER LETTERS
- miR-21 and miR-145 cooperation in regulation of colon cancer stem cells
- (2015) Yingjie Yu et al. Molecular Cancer
- MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma
- (2015) Liron Zehavi et al. Molecular Cancer
- Trametinib radiosensitises RAS- and BRAF-mutated melanoma by perturbing cell cycle and inducing senescence
- (2015) Ulrike Schick et al. RADIOTHERAPY AND ONCOLOGY
- Molecular drivers of cellular metabolic reprogramming in melanoma
- (2015) Cecilie Abildgaard et al. TRENDS IN MOLECULAR MEDICINE
- MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1
- (2015) Meizhu Zheng et al. TUMOR BIOLOGY
- Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer
- (2015) Igor Vujic et al. Oncotarget
- miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2
- (2015) Szu-Mam Liu et al. Oncotarget
- Molecular Pathways: Targeting NRAS in Melanoma and Acute Myelogenous Leukemia
- (2014) D. B. Johnson et al. CLINICAL CANCER RESEARCH
- NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract—A study of 24 cases from the Netherlands
- (2014) Adriana C.H. van Engen-van Grunsven et al. GYNECOLOGIC ONCOLOGY
- Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
- (2014) Deborah JL Wong et al. Molecular Cancer
- Optimal Management of Metastatic Melanoma: Current Strategies and Future Directions
- (2013) Marta Batus et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Emerging insights into resistance to BRAF inhibitors in melanoma
- (2013) Amanda D. Bucheit et al. BIOCHEMICAL PHARMACOLOGY
- MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6
- (2013) Yuan Shao et al. Cancer Cell International
- PI3K and MEK inhibitor combinations: examining the evidence in selected tumor types
- (2013) Carolyn D. Britten CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Characteristics of Lung Cancers Harboring NRAS Mutations
- (2013) K. Ohashi et al. CLINICAL CANCER RESEARCH
- Overexpression of miR-145 increases the sensitivity of vemurafenib in drug-resistant colo205 cell line
- (2013) Wei Peng et al. TUMOR BIOLOGY
- Melanoma as a model tumour for immuno-oncology
- (2012) M. Maio ANNALS OF ONCOLOGY
- MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF
- (2012) Chao Zou et al. CELL CYCLE
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- NRAS mutant melanoma: biological behavior and future strategies for therapeutic management
- (2012) I V Fedorenko et al. ONCOGENE
- The molecular mechanism of microRNA-145 to suppress invasion–metastasis cascade in gastric cancer
- (2012) P Gao et al. ONCOGENE
- A Functional Screen Identifies Specific MicroRNAs Capable of Inhibiting Human Melanoma Cell Viability
- (2012) Jos B. Poell et al. PLoS One
- NRAS mutation status is an independent prognostic factor in metastatic melanoma
- (2011) John A. Jakob et al. CANCER
- Prognostic and Clinicopathologic Associations of OncogenicBRAFin Metastatic Melanoma
- (2011) Georgina V. Long et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparative Study of Anti-Oncogenic MicroRNA-145 in Canine and Human Malignant Melanoma
- (2011) Shunsuke NOGUCHI et al. JOURNAL OF VETERINARY MEDICAL SCIENCE
- The miRNA expression profile of the uveal melanoma
- (2011) ChengHsun Yang et al. Science China-Life Sciences
- Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway
- (2010) O. A. Kent et al. GENES & DEVELOPMENT
- Real-time monitoring of cell transplantation in mouse dystrophic muscles by a secreted alkaline phosphatase reporter gene
- (2009) X Gerard et al. GENE THERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now